Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170069893> ?p ?o ?g. }
- W2170069893 endingPage "54" @default.
- W2170069893 startingPage "145" @default.
- W2170069893 abstract "Interleukin-2 (IL-2) shows encouraging clinical results in metastatic renal cell carcinoma (RCC) patients, but is limited by substantial toxicity. Cell-based therapy holds a promise, but past attempts in RCC were unsuccessful. Advances in tumor-infiltrating lymphocytes (TIL) generation technology and modified clinical protocols recently yielded a 50% response in refractory melanoma patients.RCC-derived TIL and tumor cells were processed by current protocols from tumor specimens in a clean laboratory. The expanded TIL were characterized and tested in functional assays.The TIL cultures were efficiently generated and massively expanded. Virtually all the expanded cells were T-cells, but a considerable variability in the CD4/CD8 ratio and a frequent CD4-CD8-phenotype were observed. The TIL exerted cytotoxic or IFNgamma-release activities against autologous targets in major histocompatibility (MHC) class I-restricted and -independent functional patterns. The functional results were superior to former technologies.Recent developments in TIL generation technology and clinical patient conditioning protocols indicate that the TIL-based approach for RCC could be revisited." @default.
- W2170069893 created "2016-06-24" @default.
- W2170069893 creator A5003553736 @default.
- W2170069893 creator A5011378386 @default.
- W2170069893 creator A5026967523 @default.
- W2170069893 creator A5032522660 @default.
- W2170069893 creator A5034865472 @default.
- W2170069893 creator A5036952733 @default.
- W2170069893 creator A5043541845 @default.
- W2170069893 creator A5046917164 @default.
- W2170069893 creator A5064670126 @default.
- W2170069893 creator A5067878298 @default.
- W2170069893 creator A5074455147 @default.
- W2170069893 creator A5090975001 @default.
- W2170069893 date "2009-01-01" @default.
- W2170069893 modified "2023-10-16" @default.
- W2170069893 title "Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma." @default.
- W2170069893 cites W1503689586 @default.
- W2170069893 cites W1865252469 @default.
- W2170069893 cites W1957293994 @default.
- W2170069893 cites W1964382251 @default.
- W2170069893 cites W1970754601 @default.
- W2170069893 cites W1982538054 @default.
- W2170069893 cites W1984497421 @default.
- W2170069893 cites W1991287153 @default.
- W2170069893 cites W1992350807 @default.
- W2170069893 cites W1993215425 @default.
- W2170069893 cites W1993396683 @default.
- W2170069893 cites W1995012480 @default.
- W2170069893 cites W1999971211 @default.
- W2170069893 cites W2010594131 @default.
- W2170069893 cites W2010922182 @default.
- W2170069893 cites W2025195265 @default.
- W2170069893 cites W2027061830 @default.
- W2170069893 cites W2048422848 @default.
- W2170069893 cites W2052937977 @default.
- W2170069893 cites W2053364576 @default.
- W2170069893 cites W2058899594 @default.
- W2170069893 cites W2067874984 @default.
- W2170069893 cites W2071378220 @default.
- W2170069893 cites W2076349082 @default.
- W2170069893 cites W2081447339 @default.
- W2170069893 cites W2082649032 @default.
- W2170069893 cites W2097633205 @default.
- W2170069893 cites W2110978714 @default.
- W2170069893 cites W2115511126 @default.
- W2170069893 cites W2147675206 @default.
- W2170069893 cites W2148188481 @default.
- W2170069893 cites W2148523692 @default.
- W2170069893 cites W2151246207 @default.
- W2170069893 cites W2155362090 @default.
- W2170069893 cites W2155690142 @default.
- W2170069893 cites W2157584612 @default.
- W2170069893 cites W2262065831 @default.
- W2170069893 cites W2335678767 @default.
- W2170069893 cites W2396047931 @default.
- W2170069893 cites W2403090897 @default.
- W2170069893 cites W2412874069 @default.
- W2170069893 cites W2440468425 @default.
- W2170069893 cites W2413642993 @default.
- W2170069893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19331144" @default.
- W2170069893 hasPublicationYear "2009" @default.
- W2170069893 type Work @default.
- W2170069893 sameAs 2170069893 @default.
- W2170069893 citedByCount "9" @default.
- W2170069893 countsByYear W21700698932015 @default.
- W2170069893 countsByYear W21700698932017 @default.
- W2170069893 countsByYear W21700698932018 @default.
- W2170069893 countsByYear W21700698932019 @default.
- W2170069893 countsByYear W21700698932021 @default.
- W2170069893 countsByYear W21700698932022 @default.
- W2170069893 countsByYear W21700698932023 @default.
- W2170069893 crossrefType "journal-article" @default.
- W2170069893 hasAuthorship W2170069893A5003553736 @default.
- W2170069893 hasAuthorship W2170069893A5011378386 @default.
- W2170069893 hasAuthorship W2170069893A5026967523 @default.
- W2170069893 hasAuthorship W2170069893A5032522660 @default.
- W2170069893 hasAuthorship W2170069893A5034865472 @default.
- W2170069893 hasAuthorship W2170069893A5036952733 @default.
- W2170069893 hasAuthorship W2170069893A5043541845 @default.
- W2170069893 hasAuthorship W2170069893A5046917164 @default.
- W2170069893 hasAuthorship W2170069893A5064670126 @default.
- W2170069893 hasAuthorship W2170069893A5067878298 @default.
- W2170069893 hasAuthorship W2170069893A5074455147 @default.
- W2170069893 hasAuthorship W2170069893A5090975001 @default.
- W2170069893 hasConcept C10882517 @default.
- W2170069893 hasConcept C143998085 @default.
- W2170069893 hasConcept C1491633281 @default.
- W2170069893 hasConcept C154317977 @default.
- W2170069893 hasConcept C167672396 @default.
- W2170069893 hasConcept C202751555 @default.
- W2170069893 hasConcept C203014093 @default.
- W2170069893 hasConcept C207936829 @default.
- W2170069893 hasConcept C2776090121 @default.
- W2170069893 hasConcept C2777472916 @default.
- W2170069893 hasConcept C2777658100 @default.
- W2170069893 hasConcept C2777701055 @default.
- W2170069893 hasConcept C2778326572 @default.